Safety Considerations for GLP-1 Use Without a Gallbladder Research on semaglutide use in post-cholecystectomy patients is limited, but current evidence does not identify gallbladder removal as an absolute contraindication
Whether youve been sidelined by an injury, are seeking quicker recovery after a grueling workout, or want to explore cutting-edge tools for athletic performance, this guide will unpack what BPC-157 and TB-500 bring to the table and how science supports their use
Rather than replacing earlier peptides, each new generation gives researchers another way to explore the complexity of metabolic biology
We're really starting to dramatically improve outcomes for people with diabetes and kidney disease
For context, in other studies with different study designs and subject-level differences, researchers have documented weight reductions of up to ~5% with other drugs, e.g., 72% with 2 mg semaglutide after treatment periods of up to 68 weeks